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SUMMARY 
De novo malignant tumors have been observed throughout the world in 75 chronic 
survivors of organ transplantation, including 16 of our own patients. The incidence of 
tumors was approximately 80 times greater than in the average population in a compara-
ble age range. Chronic uremia may have predisposed to the development of some of the 
tumors, but this has not yet been proved. It seems clear that the predominant etiology 
was chronic immunosuppression post-transplantation. Forty-four of the patients had 
epithelial tumors and in 31 the lesions were of mesenchymal origin. On the average the 
malignancies appeared 29 months after transplantation. Lymphomas showed an unusual 
predilection for involvement of the central nervous system. Carcinomas of the skin, lip, 
and uterine cervix were successfully treated by conventional techniques. On the other 
hand, carcinomas of the thoracic or abdominal organs and mesenchymal tumors led or 
contributed to early death in most cases. For this reason drastic reduction or even 
discontinuance of immunosuppression should be considered in the management of these 
, latter tumors. 
" II~ tn recent years a convincing association be-
tween immunosuppression and malignant neo-
pln.Sms in organ transplant recipients has be-
;omeevident. In some patients tumors have 
''tlt'.n: accidentally transplanted from donors with 
Dy~!lr (15, 28, 29), or there has been growth of 
-"sidual or metastatic tumor in patients with 
:;r~xisting malignancy (15, 28, 29), or neo-
~fK:tsms have arisen de novo at some time after 
'r:lIlspIantation. This report will be restricted to 
Dh~last group of tumors. 
'. 
IThis" ' • 
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lll~by Grants AI-I0176-0l, Af-AM~UU9UI AM-
'ii'i2, and eb~911M from the United States Pub-
After we first described the development of de 
novo malignancies in renal homograft recipients 
in 1968 (18, 25, 27), an informal tumor registry 
was established in Denver. Physicians from 
transplant centers throughout the world have 
generously contributed data concerning their pa-
tients. The present report deals with all cases 
recorded until December 31, 1971 and involves 
75 patients with 76 types of tumors. 
INCIDENCE 
Up to the fall of 1971, 7,581 renal and 179 
cardiac homografts had been reported to the 
American Cancer Society-National Institutes of 
Health Organ Transplant Registry (2). How-
ever, it is well recognized that these figures are 
incomplete as are the numbers of tumors re-
ported. In order to determine accurately the in-
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viewed the renal transplantation experience at 
the University of Colorado Medical Center and 
the Denver Veterans Administration Hospital. 
The studies invoh-ed patients treated between 
~ovember 1962 and July 1, 1971, who on De-
cember 31, 1971 had potential followups of from 
6 months to more than 9 years. Sixteen of 352 
patients had developed tumors (Tables 1 and 2) , 
giving a crude incidence of 4.5%. This figure 
does not reflect the true frequency of post-trans-
plantation neoplasia, since 66 patients died of a 
variety of other complications before the end of 
the 4th postoperative month. The 16 tumors 
occurred in the remaining 286 patients for a 
partially corrected incidence of 5.6%. This 
correction, obtained by excluding from the de-
nominator those patients who did not survive a 
minimum of 4 months after transplantation, 
may no longer be justified, since tumors have 
been diagnosed in several centers during this 
early period as will be described later. 
The rate of tumor development in these gen-
erally young patients· (3V2-53 years old, average 
age approximately 28 years) compares with an 
annual incidence of 58/100,000 (0.058%) in the 
general population in a comparable age range 
(7). The latter statistic excludes carcinomas in 
situ. In our transplant series 3 of the 16 malig-
nancies were of this kind. Even if these 3 cases 
are omitted the incidence of malignancy in the 
286 patients is 4.5%, still a high figure. 
TUMOR TYPES 
AND ORGANS AFFECTED 
Of the 76 tumors reported to date, 44 were of 
epithelial origin (Table 1). The most common of 
these were squamous or basal cell skin carcino-
mas (11 cases), in situ carcinomas of the cervix 
uteri (8 cases), carcinomas of the lip (8 cases), 
carcinomas of the lung (3 cases), hepatomas (2 
cases), colonic carcinomas (2 cases), and highly 
anaplastic carcinomas of uncertain origin (2 
cases). In addition, there was one example each 
of carcinoma of the ovary, testis, floor of the 
mouth, stomach, thyroid, and breast. In a further 
Case the origin of a widespread squamous cell 
neoplasm was never established. There was also 
& case of a primary carcinoma involving the 
transplanted kidney (case 42, Table 1), but 
there is some question as to whether this was 
truly a de novo neoplasm or whether a small 
IlDdetected tumor may have been present in the 
organ at the time it was harvested from a ca-
daver donor. 
Thirty-two mesenchymal tumors were encoun-
tered in 31 patients (Table 2). These neoplasms 
were a. much more homogenous group in that 28 
were varieties of lymphoma including 21 exam-
ples of reticulum cell sarcoma. One of the latter 
patients also had a Kaposi's sarcoma. This type 
of lesion was found in two further patients, 
while unclassified lymphomas were found in 3, 
and a lymphosarcoma was found in 1. Of the 
nonlymphomatous tumors, 2 were leiomyosarco-
mas, 1 was a synovial sarcoma, and 1 was a 
rhabdomyosarcoma. 
An unusual feature of the lymphomas was the 
frequency with which the central nervous system 
was involved (21, 22). Of the 27 patients with 
lymphoma there were 14 with involvement of 
either the brain or spinal cord including 10 of 
the patients with reticulum cell sarcoma, 3 with 
unclassified lymphoma, and 1 patient with lym-
phosarcoma. Lymphoreticular tumors within the 
central nervous system are uncommon (0.04 and 
l.5% in two large series) (19, 20); yet, in 11 
instances in the present study, the brain or 
spinal cord were the only regions so affected. 
Probable explanations for the high incidence of 
central nervous system involvement have been 
discussed elsewhere (17, 21, 22). 
BEHAVIOR OF TUMORS 
The mesenchymal tumors occurred in a 
slightly younger average age group than the epi-
thelial lesions, 31 years compared with 35 years. 
The aye rage time of appearance of the tumors 
after transplantation was 29 months. The mes-
enchymal neoplasms occurred at an average of 
21 months after operation comparM with the 
longer interval of 35 months with the carcino-
mas. 
A number of the epithelial tumors were of low 
grade malignancy and were treated successfully 
by conventional techniques (Table 1). Of the 44 
patients in this group, 26 are currently alive 
including most of the patients with carcinomas 
of the skin, cervix uteri, and lip. The deaths of 3 
patients with these latter lesions were unrelated 
to cancer. In contrast, the epithelial malignan-
cies ,vithin the thorax and abdomen were the 
primary cause of death or contributed signifi-
cantly to the fatal outcome. The recipients with 
mesenchymal tumors had a similar gloomy prog-





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































414 TRANSPLANTATION Vol. 14, NO.4 
nosis in that only 3 of the 31 patients are cur-
rently alive. 
BORDERLINE LESIONS 
An interesting feature of the present report is 
that in 6 of the 75 cases, the lesions were diag-
nosed in less than 4 months after transplanta-
tion (Tables 1 and 2). These included one case 
each of carcinoma of the skin, testis, colon, and 
thyroid gland, a lymphosarcoma of the brain, 
and a lymphoma of the spinal cord. One reason-
able explanation could be that at least some of 
these tumors or eyen some of those with a later 
appearance were already present at the time of 
transplantation, but were small and undetected, 
and grew ].'apidly under the intiuence of the im-
munosuppressh-e therapy. This rnises the ques-
tion whether chronic renal failure per se may 
predispose the patient to malignant disease (15) 
by virtue of the well known depression in ure-
mia of immune responses (6, 10, 13, 32). 
Observations reported to the National Di-
alysis Registry (5) are neither for nor against 
this hypothesis. Among 4,600 patients on chronic 
dialysis programs, 1% were reported to have 
died from malignancies. However, these statistics 
were incomplete, llS the cause of death in 770 of 
the patients was not known; besides, the pa-
tients' ages were not stated so it is not possible 
to compare cancer death rates in this group with 
those in the general population. Furthermore, 
the Dialysis Registry does not provide figures 
gidng the incidence of tumors among living di-
alysis patients. 
Among our own 352 renal recipients, there 
have been 3 patients who were proved to have 
malignant growths prior to transplantation. The 
lesions were of the bladder, the thyroid, and the 
skin. The thyroid carcinoma was an incidental 
finding at autopsy following sudden death 2 days 
after transplantation, but the bladder and skin 
cancers required surgical manngement both be-
fore and after transplantation. These latter tu-
mors are now under control with post-transplan-
tntion followups of 1 and 2];2 years. 
A similar case to our thyroid carcinoma was 
in a patient of Dr. R. Simmons (personal com-
munication) who underwent a parathyroid-
ectomy 2 weeks after renal transplantation 
and was found to have an unsuspected papillary 
carcinoma of the thyroid gland. A patient on 
chronic hemodialysis at our medical center (A. 
Alfrey, personal communication) was also found 
to have a carcinoma of the thyroid gland during 
parathyroidectomy. Other malignancies encoun_ 
tered in patients with chronic uremia include a 
carcinoma of the parathyroid gland discovered 
during thymectomy performed 2 months before 
renal transplantation (S_ Nakamoto, personal 
communication), a rhabdomyosarcoma of the 
shoulder in a patient on hemodialysis who was 
awaiting a cadaver kidney transplant (P. Ivall-
O\,itch, personal communication), and a carci-
noma of the ureter in a patient with chronic 
renal failure caused by analgesic nephropathy 
(M. Robertson, personal communication). 
If uremia predisposed to malignancy by loss 
of immunological surveillance, it would not be 
surprising if carcinomas were found in the dis-
eased native kidneys that are often excised be-
fore or at the time of transplantation. In our 
own case material, there haye been no such ex-
amples. However, 12 cases of renal neoplasia 
have now been collected in patients with chronic 
renal failure. The features of these interesting 
cases are listed in Table 3. 
ETIOLOGY OF TUMORS 
Apart from the possibility of preexisting neo-
plasia in the recipients, it is necessary to consi-
der whether tumors were inadvertently trans-
planted from the donors. The 75 recipients re-
ceived their transplants hom 85 donors, 41 liv-
ing volunteers, and 44 cadavers. None of the 
living donors has manifested eYidence of malig-
nant disease during followup periods as long as 9 
years. Two cadaver donors (cases 4 and 28, 
Table 2) had medulloblastomas, whereas the re-
cipients subsequently developed a gluteal reticu-
lum cell sarcoma and a gastric leiomyosarcoma, 
respectively. The tumors in donor and recipient 
were morphologically distinct and there was 
probably no etiological connection unless they 
were both caused by an oncogenic virus that was 
transmitted with the donor kidney. A further 
cadaver donor (case 9, Table 2) had had a carci-
noma of the colon resected 5 years previously 
but was apparently free of tumor at the time of 
transplantation. The recipient dewloped a retic-
ulum cell sarcoma. 
In experimental animals (15, 26, 28), each of 
the main immunosuppressive agents, azathio-
prine, prednisone, and antilymphocyte globulin 
(ALG) , has been shown either to: (1) increase 
I ""b" 
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TABL.; 3. Renal neoplasms in patients with chronic uremil1 
-
I 
Case Transplant or Age Sex Underlying Type of :'Ifode of Relationship to Referring No. dialysIs center (years) renal disease tumor presentation transplantation physician 
-
------
I Minneapolis 45 F Chronic glomer· IIyperneph - :\fass in upper pole Not trdKns~ R. Simmons 
ulonephritis roma of righ t of right kidney planted; on 
kidney hemodialysis 
2 San Francisco 29 If Chronic glomer· Renal cell car- Incidental finding Twent" montbs F. Belzer 
ulonephritis cinoma of left at bilateral neph· before trans-
kidney invad· rectomy plantation 
ing capsule and 
perinephric 
fat 
3 Cleveland Not Not Not stated Renal cell car· Incidental finding Four weeks be- S.Nakamoto 
stated stated cinoma involv- at nep hrectomy fore tran"plan-
ing a solitary tation 
kidney 
• Edinburgb Not Not Not stated Hyperneph-
Incidental finding After tran.plan- M. Woodruff 
stated stated roma of one of at bilateral nepb- tation . 
the kidneys rectomy Ior per-
sistent hyperten-
sion 
64 New York 18 II End stage renal Low grade papil- Incidental finding At tbe time of R.Porro 
(Cornell) disease lary renal car· wben kidneys re transplanta-
cinoma of right mo,-ed tion 
kidney 
6" Boston 34 )1 Cbronic glomer· (1) Well differen· Incidental finding At tbe time of a R. E. Wilson 
ulonepbritis tiated renal ceU wben kidneys second trans· 
carcinoma of removed plantation 3 
Jeft kidney; (2) month. after 
two adenomas insertion of a 
of rigbt kid- first homograft 
neY' which never 
functioned 
7 Ann Arbor 43 M End stage renal Renal cell car· Incidental finding At tbe time of J. Turcotte 
disease cinoma of rigbt when kidneys re- transplanta-
kidney moved tion 
8 London 44 M Hyperparatby· Renal carcinoma Incidental finding Ten months be- J. Salaman 
roidism witb of botb kid- wben kidneys fore transplan' 
nepbroca!· neys removed tation 
cinosis 
9 Los Angeles 35 M Malignant hy· Hyperneph- Massive retroperi- Fifteen montbs T. Berne 
p.,rtension roma of a kid- toneal hemor- before traoa-
ney rbage from the plantation 
affected kidney 
JO Dallas 21 M Chronic glomer· Renal cell car- GrO&l bematuria Not trans- P.Peters 
ulonephriti. cinoma in one at age 18 years planted; on 
of his kidneys approximately 15 chronic hemo· 
months atter im~ dialysis for ap-
munosuppres- proximately 3 ; 
siva treatment years 
witb Imuran and 
predniso ne was 
started; workup 
showed mass le-
sion in ODe kid .. 
ney 
11 Minneapolis 48 F Chronic pyelo. Adenoma of left Incidental finding A waiting trans- R. Simmons 
nepbritis kidneyb at bilateral neph- plantation 
rectomy 
12 Tucson 43 M Chronic glomer· Adenoma of Jett Incidental finding Several weeks C. Zukoski 
ulonepbritis kidneY' at bilateral neph· before trans-
rectomy plantation 
• These patients .... cases 8 and 28 in Table 2. 
b There is considerable disagreement among patbologists concerning tbe difference between a large renal adenoma and a small 
I'1!naJ carcinoma. A lesion I ... than 2 em in diameter is often regarded as an adenoma and a larger lesion is often regarded as a car· 
cinoma. 
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the incidence of spontaneous, virus-induced, or 
chemically initiated tumors; (2) facilitate the 
ease with which malignant cells can be trans-
planted; or (3) accelerate metastatic growth. 
Thymectomy or splenectomy may also cause in-
creased oncogenic susceptibility in experimental 
animals (15,26, 28). 
In man there has so far been no evidence that 
anyone of the individual immunosuppressive 
measures has made a unique contribution to the 
development of post-transplantation neoplasia. 
All the patients (Tables 1 and 2) received aza-
thioprine and prednisone, 30 underwentsplenec-
tomy, 5 had ~hymectomyI and 2 had thoracic 
duct fistulas. 1t is of interest that 22 of 44 pa-
tients with epithelial tumors (50%) underwent 
splenectomy, whereas 8 of 31 (26%) with mes-
enchymal tumors were subjected to this proce-
dure. Only 21 of the 75 patients were treated 
with ALG and 2 of these recipients received this 
therapy after the appearance of the tumor. In 
yiew of these findings it is difficult to understand 
the origin of the "'idespread misconception that 
the incidence of tumors in the post-transplanta-
tion period has increased since the introduction 
of ALG therapy. 
The disproportionately high incidence of lym-
phomas may, in part, be an artefact in that 
there may be a tendency to report to the regis-
try only the more florid and lethal malignancies 
and to dismiss many skin tumors or in situ car-
cinomas of the cervix as relatively unimportant. 
However, the disproportionate numbers of lym-
phomas may be real and may reflect the effects 
upon the host of the transplanted organ with its 
foreign histocompatibility antigens. Prolonged 
antigenic stifnulation of the host reticuloen-
dothelial system has been shown to cause a high 
incidence of lymphomas (1,12,23,24,31). 
While this may be the cause of at least some 
of the lymphomas, the most likely e}.rplanation 
for the wide spectrum of tumors observed in the 
present series is that chronic immunosuppression 
causes loss of the immunological surveillance 
mechanism by which tumor mutants are nor-
mally detected and destroyed (3, 4, 30). This 
dors not exclude other possible etiological factors 
such as a direct oncogenic effect of the immuno-
suppressive agents, potentiation of the effects of 
environmental carcinogens such as tobacco, ul-
tra,;olet light, or irradiation, or activation of 
oncogenic viruses. Concerning the last possibil-
ity, infection by viruses of the Herpes family 
have been very common in transplant recipients. 
Two human strains belonging to this group, the 
Epstein-Barr and Herpes horninis II viruses 
have been found to be commonly associated with 
although not necessarily responsible for Burk-
itt's lymphoma and uterine cervical carcinoma 
respectively. ' 
TREATMENT OF TUMORS 
The epithelial malignancies of the skin, lip, 
and uterine cervix were successfully treated by 
standard surgical or radiotherapeutic techniques 
without risking the homografts by arbitrary re-
ductions in immunosuppression. This approach 
has proved inadequate for dealing with most 
carcinomas involving the thoracic and abdomi-
nal organs and with most mesenchymal tumors. 
In view of the virtually hopeless prognosis it 
may be advisable to reduce drastically or even 
discontinue the immunosuppressive therapy. 
Three patients (cases 18, 21, and 23, Table 2) 
with mesenchymal tumors are currently alive 
following this form of treatment. One of the 
patients (case 23) is in excellent health more 
than 4Y2 years after transplantation and 4 years 
after the tumor was diagnosed. Two other pa-
tients (case 20, Table 2; case 37, Table 1), in 
whom immunosuppression was drastically re-
duced, died of septicemia and rejection, respec-
tively, but at autopsy it was found that the 
previously widespread tumors had completely 
regressed. 
If drastic reduction in immunosuppression 
fails to control the neoplasm, then some form of 
immunotherapy can be attempted (9,11,14). 
FUTURE PROSPECTS 
The development of de novo malignant tu-
mors in chronically immunosuppressed organ 
transplant recipients has added a new dimension 
to our understanding of the nature of cancer by 
emphasizing the role played by immune mecha-
nisms in the control of neoplasia. Fortunately, 
the incidence of tumors is sufficiently low as not 
to contraindicate transplantation as a form of 
therapy. Much remains to be learned about the 
nature of the tumors. Electron microscope and 
culture studies are currently in progress to de-. 
termine the role played by oncogenic viruses. 
Other investigations are aimed at determining 
whether patients with particular HL-A specifici-
ties may be more prone to the development of. 
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phoma (8) or whether ccrtain HL-A mismatches 
between donor and recipient might lead to ma-
lignant change. 
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